AXGN vs CBLL: stock comparison and AI forecast
Axogen, Inc. (AXGN) and Ceribell, Inc. (CBLL) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AXGN Axogen, Inc.
- Market Cap
- $2.91B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
CBLL Ceribell, Inc.
- Price
- $26.01 +27.6% · 6M
- Market Cap
- $998M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- AXGN is 2.9 times larger than CBLL by market capitalization ($2.91B against $998M).
- CBLL carries 0.33 times debt per unit of equity, against 0.11 times for AXGN.
- Both companies share the SEC industry classification Electromedical & Electrotherapeutic Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AXGN | CBLL |
|---|---|---|
| Market Cap | $2.91B | $998M |
| P/B Ratio | 5.87x | 8.49x |
| EPS | $-0.31 | $-2.15 |
| Book Value/Share | $8.31 | $3.06 |
| Revenue/Share | $4.47 | $2.83 |
| FCF/Share | $0.37 | $-1.47 |
Profitability & Margins
| Metric | AXGN | CBLL |
|---|---|---|
| ROE | – | -62.9% |
| ROA | – | -47.2% |
| ROIC | -2.7% | -54.8% |
| Gross Margin | 74.2% | 89.3% |
| Operating Margin | -5.2% | -69.8% |
| Net Margin | – | -68.0% |
| EBT Margin | -5.2% | -68.0% |
| Tax Rate | 0.0% | – |
Financial Health
| Metric | AXGN | CBLL |
|---|---|---|
| Current Ratio | 12.02x | 8.18x |
| Quick Ratio | 10.67x | 7.79x |
| D/E Ratio | 0.11x | 0.33x |
| Financial Leverage | 1.11x | 1.33x |
| Interest Coverage | 1.5x | -77.0x |
| Working Capital | $402M | $129M |
Cash Flow
| Metric | AXGN | CBLL |
|---|---|---|
| Operating Cash Flow | $28M | -$56M |
| Free Cash Flow | $22M | -$56M |
| Capital Spending | -$6M | -$420K |
| OCF Growth YoY | 335.7% | – |
| FCF Growth YoY | 559.6% | – |
| FCF/Sales | 8.3% | -51.9% |
| CapEx/Sales | 2.4% | 0.4% |
Operational Efficiency
| Metric | AXGN | CBLL |
|---|---|---|
| Asset Turnover | 0.49x | 0.70x |
| Receivables Turnover | 7.8x | 6.1x |
| Inventory Turnover | 1.4x | 1.7x |
| Fixed Assets Turnover | 3.3x | 61.3x |
| Days Sales Outstanding | 46 days | 60 days |
| Days Inventory | 260 days | 217 days |
| Payables Period | 183 days | 73 days |
| Cash Conversion Cycle | 123 days | 204 days |
Income Statement
| Metric | AXGN | CBLL |
|---|---|---|
| Total Revenue | $267M | $109M |
| Operating Income | -$14M | -$76M |
| Net Income | – | -$74M |
| R&D Expense | $37M | $25M |
| SG&A Expense | $287M | $193M |
| Cost of Goods Sold | $69M | $12M |
Dividend & Shareholder Information
| Metric | AXGN | CBLL |
|---|---|---|
| Shares Outstanding | 60M | 38M |
AXGN vs CBLL: stock comparison and AI forecast
Which is bigger, AXGN or CBLL?
AXGN is 2.9 times larger than CBLL by market capitalization ($2.91B against $998M).
Which one does Intratio's AI model rank higher, AXGN or CBLL?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.